Related Experiment Video
Updated: Apr 18, 2026

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Published on: July 22, 2020
Identification of constrained cancer driver genes based on mutation timing
Thomas Sakoparnig1, Patrick Fried1, Niko Beerenwinkel1
1Department of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland; SIB Swiss Institute of Bioinformatics, Basel, Switzerland.
This study introduces a new computational method to identify low-frequency cancer driver mutations. The approach analyzes mutation timing to distinguish drivers from passengers, revealing new cancer-driving genes.
Area of Science:
- Genomics
- Computational Biology
- Cancer Research
Background:
- Cancer driver mutations confer a selective advantage, typically identified by high recurrence in tumors.
- Many driver mutations may occur at low frequencies, challenging traditional detection methods.
- Existing methods include identifying mutually exclusive mutations and incorporating biological network knowledge.
Purpose of the Study:
- To develop a novel computational approach for detecting low-frequency cancer driver mutations.
- To identify driver mutations that are dependent on other genomic events and exhibit punctuated temporal patterns.
- To complement existing driver detection strategies by incorporating mutation timing.
Main Methods:
- Developed a computational method to identify genomic alterations with low frequencies due to dependencies on other events.
- Utilized mutation timing analysis to discriminate between driver and passenger mutations.
- Applied the approach to copy number alteration (CNA) and single-nucleotide variant (SNV) data from ovarian, breast, and colorectal cancers.
Main Results:
- The mutation timing approach successfully identified low-frequency driver mutations.
- Validated the method through extensive simulation studies.
- Discovered known and novel candidate driver genes involved in carcinogenesis across multiple cancer types.
Conclusions:
- The developed method effectively identifies low-frequency cancer drivers by analyzing mutation timing.
- This approach is complementary to existing driver prediction methods.
- It aids in uncovering crucial alterations driving tumor progression from cancer genome data.
More Related Videos
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
11:20Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology
Published on: March 21, 2018
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes